229 related articles for article (PubMed ID: 32669888)
1. Counterfeit drugs and medical devices in developing countries.
Glass BD
Res Rep Trop Med; 2014; 5():11-22. PubMed ID: 32669888
[TBL] [Abstract][Full Text] [Related]
2. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
Nsimba SE
East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
[TBL] [Abstract][Full Text] [Related]
3. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries.
Tadeg H; Berhane Y
East Afr J Public Health; 2012 Jun; 9(2):85-9. PubMed ID: 23139963
[TBL] [Abstract][Full Text] [Related]
4. [Counterfeit medicines--Japan and the world].
Sato D
Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
[TBL] [Abstract][Full Text] [Related]
5. Update on counterfeit antibiotics worldwide; public health risks.
Delepierre A; Gayot A; Carpentier A
Med Mal Infect; 2012 Jun; 42(6):247-55. PubMed ID: 22621827
[TBL] [Abstract][Full Text] [Related]
6. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
7. Substandard and counterfeit medicines: a systematic review of the literature.
Almuzaini T; Choonara I; Sammons H
BMJ Open; 2013 Aug; 3(8):e002923. PubMed ID: 23955188
[TBL] [Abstract][Full Text] [Related]
8. [Counterfeit medicines: a growing threat].
Barbereau S
Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
[TBL] [Abstract][Full Text] [Related]
9. [Counterfeit drugs as a gobal threat to health].
Golocorbin Kon S; Mikov M
Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
[TBL] [Abstract][Full Text] [Related]
10. The health and economic effects of counterfeit drugs.
Blackstone EA; Fuhr JP; Pociask S
Am Health Drug Benefits; 2014 Jun; 7(4):216-24. PubMed ID: 25126373
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Counterfeit pharmaceuticals: current status and future projections.
Wertheimer AI; Chaney NM; Santella T
J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
[TBL] [Abstract][Full Text] [Related]
13. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.
Mackey TK; Liang BA
BMC Med; 2013 Oct; 11():233. PubMed ID: 24228892
[TBL] [Abstract][Full Text] [Related]
14. Are we doing enough to prevent poor-quality antimalarial medicines in the developing world?
Walker EJ; Peterson GM; Grech J; Paragalli E; Thomas J
BMC Public Health; 2018 May; 18(1):630. PubMed ID: 29764407
[TBL] [Abstract][Full Text] [Related]
15. I (Don't) want to consume counterfeit medicines: exploratory study on the antecedents of consumer attitudes toward counterfeit medicines.
Ofori-Parku SS; Park SE
BMC Public Health; 2022 Jun; 22(1):1094. PubMed ID: 35650557
[TBL] [Abstract][Full Text] [Related]
16. Spurious and counterfeit drugs: a growing industry in the developing world.
Gautam CS; Utreja A; Singal GL
Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
[TBL] [Abstract][Full Text] [Related]
17. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
[TBL] [Abstract][Full Text] [Related]
18. Tackling Counterfeit Drugs: The Challenges and Possibilities.
Pathak R; Gaur V; Sankrityayan H; Gogtay J
Pharmaceut Med; 2023 Jul; 37(4):281-290. PubMed ID: 37188891
[TBL] [Abstract][Full Text] [Related]
19. Microbiological contamination in counterfeit and unapproved drugs.
Pullirsch D; Bellemare J; Hackl A; Trottier YL; Mayrhofer A; Schindl H; Taillon C; Gartner C; Hottowy B; Beck G; Gagnon J
BMC Pharmacol Toxicol; 2014 Jun; 15():34. PubMed ID: 24965483
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
